Related Experiment Video
Updated: Dec 28, 2025

06:23
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
33.6K
Morphometric network differences in ageing versus Alzheimer's disease dementia.
Alexa Pichet Binette1,2, Julie Gonneaud2, Jacob W Vogel3
1Department of Psychiatry, Faculty of Medicine, McGill University, Montreal, Qc, H3A 1Y2, Canada.
Brain : a Journal of Neurology
|February 11, 2020
Summary
Brain ageing and Alzheimer's disease both cause grey matter loss. However, disrupted brain organization, not just volume, uniquely identifies Alzheimer's disease and predicts cognitive decline.
Area of Science:
- Neuroimaging
- Neuroscience
- Gerontology
Background:
- Distinguishing normal brain aging from Alzheimer's disease (AD) is challenging due to age being a primary risk factor for AD.
- Previous studies often focused only on older adults and predefined brain regions.
- A comprehensive understanding requires analyzing structural changes across the lifespan and in relation to AD pathology.
Purpose of the Study:
- To investigate grey matter organization and volume differences in normal aging versus Alzheimer's disease.
- To determine if structural brain differences can discriminate between aging and AD.
- To explore the relationship between brain structure and clinical progression.
Main Methods:
- Utilized a large, multi-cohort dataset including young adults, cognitively intact older adults, and individuals with mild cognitive impairment or AD dementia.
- Applied independent component analysis (ICA) on structural MRI data to derive morphometric networks and grey matter volumes.
- Assessed whole-brain grey matter pattern organization, interindividual heterogeneity, and used logistic regression and ROC analyses for discrimination.
Main Results:
- Both aging and AD showed additive effects on grey matter volume in most networks; frontal lobe differences were specific to aging.
- No specific networks discriminated AD from aging, but heterogeneity in grey matter across networks and whole-brain patterns characterized cognitive impairment.
- Preservation of the whole-brain grey matter pattern was a stronger predictor of lower cognitive decline risk than grey matter volume.
Conclusions:
- Both aging and AD involve widespread grey matter atrophy.
- Disruption in morphometric organization, particularly whole-brain pattern heterogeneity, uniquely characterizes Alzheimer's disease.
- Brain organization, more than volume, is crucial for understanding cognitive impairment and predicting clinical progression in AD.
Related Concept Videos
Alzheimer's Disease: Overview
1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Dementia
458
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
458

